Cost-effectiveness of low-dose aspirin for the prevention of preterm birth: a prospective study of the Global Network for Women's and Children's Health Research

Cost-effectiveness of low-dose aspirin for the prevention of preterm birth: a prospective study of the Global Network for Women's and Children's Health Research

Summary: Background: Premature birth is associated with an increased risk of mortality and morbidity, and strategies to prevent preterm birth are few in number and resource intensive. In 2020, the ASPIRIN trial showed the efficacy of low-dose aspirin (LDA) in nulliparous, singleton pregnancies for...

Full description

Bibliographic Details
Main Authors: Jackie K Patterson, MD, Simon Neuwahl, MSPH, Norman Goco, MHS, Janet Moore, MS, Shivaprasad S Goudar, ProfMD, Richard J Derman, ProfMD, Matthew Hoffman, ProfMD, Mrityunjay Metgud, ProfMD, Manjunath Somannavar, MD, Avinash Kavi, MD, Jean Okitawutshu, MD, Adrien Lokangaka, MD, Antoinette Tshefu, ProfMD, Carl L Bose, ProfMD, Abigail Mwapule, RN, Musaku Mwenechanya, MD, Elwyn Chomba, MD, Waldemar A Carlo, ProfMD, Javier Chicuy, MD, Lester Figueroa, MD, Nancy F Krebs, ProfMD, Saleem Jessani, MBBS, Sarah Saleem, ProfMD, Robert L Goldenberg, ProfMD, Kunal Kurhe, MD, Prabir Das, MD, Archana Patel, ProfMD, Patricia L Hibberd, ProfMD, Emmah Achieng, MPH, Paul Nyongesa, MMed, Fabian Esamai, MBChB, Sherri Bucher, PhD, Edward A Liechty, ProfMD, Brian W Bresnahan, PhD, Marion Koso-Thomas, MD, Elizabeth M McClure, PhD
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X22005484

Internet

http://www.sciencedirect.com/science/article/pii/S2214109X22005484

Similar Items